信息來源：https://pubpeer.com/search?q=Songqing+He

問題文章的基本信息

（1）MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway . (MicroRNA-1908 通過抑制 PTEN 腫瘤抑制通路發揮膠質母細胞瘤致癌基因的作用)

Xuewei Xia, Yong Li, Wenbo Wang, Fang Tang, Jie Tan, Liyuan Sun, Qinghua Li, Li Sun, Bo Tang, Songqing He

Molecular Cancer 分子癌症雜誌 (2015) 。19 comments 19項披露

（2）MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5.（MicroRNA-1179靶向E2F5抑制人胰腺癌細胞增殖、遷移和侵襲）

Chengjie Lin, Zhigao Hu, Guandou Yuan, Huizhao Su, Yonglian Zeng, Zhenya Guo, Fudi Zhong, Keqing Jiang, Songqing He

Author response. 作者有回覆

Chemico-Biological Interactions 化學-生物相互作用雜誌 (2018). 8 comments披露

（3）JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells. (JARID1B 通過 PTEN/AKT 信號通路促進肝癌細胞轉移和上皮-間質轉化)

Bo Tang, Guangying Qi, Fang Tang, Shengguang Yuan, Zhenran Wang, Xingsi Liang, Bo Li, Shuiping Yu, Jie Liu, Qi Huang, Yangchao Wei, Run Zhai, Biao Lei, Hongping Yu, Xingyuan Jiao, Songqing He

Oncotarget 腫瘤靶標 (2015). 23 comments 披露

（4） Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling. (CTNND1 在肝細胞癌中的過表達通過激活 Wnt/β-catenin 信號通路促進癌變)

Bo Tang, Fang Tang, Zhenran Wang, Guangying Qi, Xingsi Liang, Bo Li, Shengguang Yuan, Jie Liu, Shuiping Yu, Songqing He

Journal of Experimental & Clinical Cancer Research 實驗與臨床癌症研究雜誌(2016).  14 comments 披露

（5）MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression. (MicroRNA-155-3p通過抑制FBXW7表達促進肝癌形成)

Bo Tang, Biao Lei, Guangying Qi, Xingsi Liang, Fang Tang, Shengguang Yuan, Zhenran Wang, Shuiping Yu, Songqing He

Journal of Experimental & Clinical Cancer Research 實驗與臨床癌症研究雜誌(2016). 7 comments 披露

（6）m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. (m6A 去甲基化酶 ALKBH5 通過降低 WIF-1 RNA 甲基化和介導 Wnt 信號通路抑制胰腺癌腫瘤發生)

Bo Tang, Yihua Yang, Min Kang, Yunshan Wang, Yan Wang, Yin Bi, Songqing He, Fumio Shimamoto

Molecular Cancer分子癌症雜誌 (2020).  3 comments 披露

（7）Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway. (異槲皮苷通過MAPK信號通路抑制體內外肝癌進展)

GUIHONG HUANG, BO TANG, KUN TANG, XIAOMIN DONG, JUNGANG DENG, LUQIN LIAO, ZENGZHEN LIAO, HUA YANG, SONGQING HE

Oncology Reports 腫瘤學報告 (2014). 3 comments 披露

（8）CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma （CBX8 具有致癌特性並可作為肝細胞癌的預後因素）

Bo Tang, Yu Tian, Yong Liao, Zeming Li, Shuiping Yu, Huizhao Su, Fudi Zhong, Guandou Yuan, Yan Wang, Hongping Yu, Stephen Tomlinson, Xiaoqiang Qiu, Songqing He

Cell Death and Disease細胞死亡和疾病 (2019). 2 comments 披露

（9）Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU RNA.(干擾下調δ阿片受體增強BEL/FU耐藥人肝癌細胞對5-FU的敏感性）

BO TANG, ZHIGAO HU, YANG LI, SHENGGUANG YUAN, ZHENRAN WANG, SHUIPING YU, SONGQING HE

ERRATUM有過糾正

Molecular Medicine Reports分子醫學報告 (2016). 3 comments

（10）Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo. (肝癌中δ阿片受體的上調在體外和體內促進肝癌進展)

BO TANG, YANG LI, SHENGGUANG YUAN, STEPHEN TOMLINSON, SONGQING HE

International Journal of Oncology (2013).  3 comments 3項披露

（11）Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression (Lnc-PDZD7 通過 EZH2 介導的 ATOH8 轉錄抑制促進肝細胞癌的乾性和化學敏感性)

Yi Zhang , Bo Tang*, Jun Song , Shuiping Yu , Yang Li , Huizhao Su , Songqing He*

Journal of Experimental & Clinical Cancer Research (2019) - 2 Comments 2項披露